Owen Adams Catherine bought ACAD
March 6, 2026 · Form 4 insider transaction
Owen Adams Catherine bought 263,005 shares of Acadia Pharmaceuticals Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
263,005
Price
$0.00
Total value
N/A
InsiderOwen Adams Catherine
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 6, 2026
Filing dateMarch 10, 2026
Shares owned after263,005
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
25% of the shares subject to the Stock Option will vest and become exercisable on March 6, 2027. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter.